The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 14, 2015
Filed:
Dec. 23, 2013
Applicant:
Selecta Biosciences, Inc., Watertown, MA (US);
Inventors:
Charles Zepp, Hardwick, MA (US);
Grayson B. Lipford, Watertown, MA (US);
Yun Gao, Southborough, MA (US);
Lloyd Johnston, Belmont, MA (US);
Fen-ni Fu, Northborough, MA (US);
Mark J. Keegan, Groton, MA (US);
Sam Baldwin, Westford, MA (US);
Assignee:
Selecta Biosciences, Inc., Watertown, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/90 (2006.01); A61K 39/385 (2006.01); A61K 9/51 (2006.01); A61K 39/00 (2006.01); A61K 47/48 (2006.01); B82Y 5/00 (2011.01); C08G 63/06 (2006.01); C08G 63/91 (2006.01); C08G 64/42 (2006.01); A61K 39/39 (2006.01);
U.S. Cl.
CPC ...
A61K 39/385 (2013.01); A61K 9/5138 (2013.01); A61K 39/0013 (2013.01); A61K 47/48176 (2013.01); A61K 47/48192 (2013.01); A61K 47/482 (2013.01); A61K 47/48215 (2013.01); A61K 47/48246 (2013.01); A61K 47/48869 (2013.01); A61K 47/48907 (2013.01); A61K 47/48915 (2013.01); B82Y 5/00 (2013.01); A61K 47/48238 (2013.01); A61K 47/48207 (2013.01); C08G 63/06 (2013.01); C08G 63/912 (2013.01); C08G 64/42 (2013.01); A61K 39/39 (2013.01); A61K 2039/55511 (2013.01); A61K 2039/55544 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/55561 (2013.01); A61K 2039/6093 (2013.01); A61K 2039/62 (2013.01);
Abstract
This invention relates to compositions, and related compounds and methods, of conjugates of immunomodulatory agents and polymers or unit(s) thereof. The conjugates may be contained within synthetic nanocarriers, and the immunomodulatory agents may be released from the synthetic nanocarriers in a pH sensitive manner.